addressing drug resistance and unresponsiveness in melanoma
Published 5 years ago • 59 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
1:11
chemotherapy for melanoma - why is it not effective and what is its future?
-
2:13
cell cycle-dependent resistance or sensitivity to drugs and the importance of mitf genes in melanoma
-
2:03
exploring adaptive drug resistance in melanoma
-
1:48
using mouse models to develop drugs targeting resistance mechanisms in melanoma
-
1:25
dr. schaider discusses drug resistance for melanoma
-
1:55
what causes skin tags and moles? – dr.berg
-
17:28
unit 3 - drug resistance in cancer
-
5:52
understanding cancer: early signs, risk factors, and prevention tips
-
1:29
why dynamic heterogeneity is important for designing drugs in melanoma
-
2:25
highlights in the development of new therapies and novel drugs in treating melanoma
-
1:48
understanding how to reduce drug resistance of metastatic melanoma
-
4:40
the current and future treatment of metastatic melanoma
-
0:55
scientists combine cancer drugs to treat melanoma
-
1:39
advancements in use of combination drugs in clinical trials: nivolumab, pembrolizumab, and more
-
29:25
drug combination in melanoma: is more better?
-
1:25
overcoming anti-melanoma drug resistance with reverse transcriptase inhibitors (rtis)
-
4:33
melanoma - overview (signs and symptoms, pathology, risk factors, treatment)
-
1:04
a pill for melanoma
-
3:07
immunotherapy and melanoma
-
44:53
overcoming drug resistance to cancer therapies
-
25:48
the genetics of melanoma: searching for new therapeutic targets - yardena samuels
-
6:03
melanoma and cutaneous malignancies -- diagnosis, treatment & survivorship at penn medicine